2-Phenyl-3-aminobutane
| Clinical data | |
|---|---|
| Other names | β-Methylamphetamine; α,β-Dimethylphenethylamine; α,β-Dimethyl-2-phenylethylamine |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H15N |
| Molar mass | 149.237 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2-Phenyl-3-aminobutane (also known as β-methylamphetamine) is a stimulant of the phenethylamine class that is closely related to its α-methyl analog Pentorex. It was first synthesized by the German scientists Felix Haffner and Fritz Sommer in 1939 as a stimulant with milder effects, shorter duration, lower toxicity and fewer side effects compared to previously known drugs such as amphetamine.
2-Phenyl-3-aminobutane is banned in some countries as a structural isomer of methamphetamine.